Considering this great impact as well as the limited evidence of the CYP2D6 phenotype in elderly patients, we designed a prospective cohort among elderly Chinese patients with cardiovascular diseases to investigate the impact of the CYP2D6 genotype on metoprolol tolerance and adverse events. The gene discussed is CYP2D6; the disease is cardiovascular disorder.